375 related articles for article (PubMed ID: 32011186)
1. Pharmacotherapy for smoking cessation in schizophrenia: a systematic review.
Kozak K; George TP
Expert Opin Pharmacother; 2020 Apr; 21(5):581-590. PubMed ID: 32011186
[No Abstract] [Full Text] [Related]
2. Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
Cahill K; Stevens S; Perera R; Lancaster T
Cochrane Database Syst Rev; 2013 May; 2013(5):CD009329. PubMed ID: 23728690
[TBL] [Abstract][Full Text] [Related]
3. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
[TBL] [Abstract][Full Text] [Related]
4. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
[TBL] [Abstract][Full Text] [Related]
5. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
[TBL] [Abstract][Full Text] [Related]
6. Interventions for smoking cessation and reduction in individuals with schizophrenia.
Tsoi DT; Porwal M; Webster AC
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD007253. PubMed ID: 23450574
[TBL] [Abstract][Full Text] [Related]
7. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
Bailey SR; Crew EE; Riske EC; Ammerman S; Robinson TN; Killen JD
Paediatr Drugs; 2012 Apr; 14(2):91-108. PubMed ID: 22248234
[TBL] [Abstract][Full Text] [Related]
9. Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.
Stead LF; Koilpillai P; Lancaster T
Cochrane Database Syst Rev; 2015 Oct; (10):CD009670. PubMed ID: 26457723
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews.
Hartmann-Boyce J; Stead LF; Cahill K; Lancaster T
Addiction; 2014 Sep; 109(9):1414-25. PubMed ID: 24995905
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological treatments for smoking cessation.
Cahill K; Stevens S; Lancaster T
JAMA; 2014 Jan; 311(2):193-4. PubMed ID: 24399558
[TBL] [Abstract][Full Text] [Related]
12. Interventions to increase adherence to medications for tobacco dependence.
Hollands GJ; Naughton F; Farley A; Lindson N; Aveyard P
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD009164. PubMed ID: 31425618
[TBL] [Abstract][Full Text] [Related]
13. Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation.
Stead LF; Lancaster T
Cochrane Database Syst Rev; 2012 Dec; 12():CD009670. PubMed ID: 23235680
[TBL] [Abstract][Full Text] [Related]
14. Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.
Hays JT; Ebbert JO
Drugs; 2010 Dec; 70(18):2357-72. PubMed ID: 21142259
[TBL] [Abstract][Full Text] [Related]
15. Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
Doggrell SA
Expert Opin Pharmacother; 2007 Dec; 8(17):2903-15. PubMed ID: 18001252
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trial.
Heffner JL; Evins AE; Russ C; Lawrence D; Ayers CR; McRae T; Aubin LS; Krishen A; West R; Anthenelli RM
J Affect Disord; 2019 Sep; 256():267-277. PubMed ID: 31195244
[TBL] [Abstract][Full Text] [Related]
17. Effect of Smoking Reduction Therapy on Smoking Cessation for Smokers without an Intention to Quit: An Updated Systematic Review and Meta-Analysis of Randomized Controlled.
Wu L; Sun S; He Y; Zeng J
Int J Environ Res Public Health; 2015 Aug; 12(9):10235-53. PubMed ID: 26308034
[TBL] [Abstract][Full Text] [Related]
18. Varenicline in the management of smoking cessation: a single technology appraisal.
Hind D; Tappenden P; Peters J; Kenjegalieva K
Health Technol Assess; 2009 Sep; 13 Suppl 2():9-13. PubMed ID: 19804684
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis.
Siskind DJ; Wu BT; Wong TT; Firth J; Kisely S
Lancet Psychiatry; 2020 Sep; 7(9):762-774. PubMed ID: 32828166
[TBL] [Abstract][Full Text] [Related]
20. Varenicline: for smoking cessation.
Rao J; Shankar PK
Kathmandu Univ Med J (KUMJ); 2009; 7(26):162-4. PubMed ID: 20071853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]